All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...

Polymyalgia rheumatica (PMR) is an elderly onset syndrome characterised by aching and stiffness ... In this view, the recognition of predominantly autoinflammatory nature of PMR should address future ...

Polymyalgia rheumatica (PMR) is a common inflammatory ... randomized controlled trials of treatment are lacking. As a result, there is no evidence from controlled studies on the efficacy of ...

Patients with predominantly cranial vs isolated extracranial GCA phenotypes present with different patterns of arterial involvement on 18F-FDG PET-CT scans.

polymyalgia rheumatica inflammation autoimmune diseases This is an open access article ... There are, however, several significant limitations, emblematic of many studies published in this early phase ...

We expect that better monitoring of disease activity and treatment responses in PMR will improve clinical decision making and, ultimately, patient care. We cordially thank the members of the EULAR ...

Responders reached clinical remission in 6.6 days in average; most of them within 10 days from onset of therapy. This observation suggests that a close follow-up in the first days after diagnosis ...

Objectives To determine whether whole-body MRI defines clinically relevant subgroups within polymyalgia rheumatica (PMR) including glucocorticoid responsiveness ... Ethical approval was obtained ...

Clinical trials help doctors and researchers find new ways to treat diseases. They can also offer patients a chance to try a potential treatment and help future patients diagnosed with the same ...

A clinical trial is one that involves human participants and seeks to answer specific questions about a type of medical intervention. This can be a drug or other type of treatment, such as nutritional ...